Unknown

Dataset Information

0

AMPK alleviates high uric acid-induced Na+-K+-ATPase signaling impairment and cell injury in renal tubules.


ABSTRACT: One of the mechanisms in hyperuricemia (HUA)-induced renal tubular injury is the impairment of Na+-K+-ATPase (NKA) signaling, which further triggers inflammation, autophagy, and mitochondrial dysfunction and leads to cell injury. Here, we used RNA sequencing to screen the most likely regulators of NKA signaling and found that the liver kinase B1(LKB1)/adenosine monophosphate (AMP)-activated protein kinase (AMPK)/ mammalian target of rapamycin (mTOR) pathway was the most abundantly enriched pathway in HUA. AMPK is a key regulator of cell energy metabolism; hence, we examined the effect of AMPK on HUA-induced dysregulation of NKA signaling and cell injury. We first detected AMPK activation in high uric acid (UA)-stimulated proximal tubular epithelial cells (PTECs). We further found that sustained treatment with the AMPK activator 5-aminoimidazole-4-carboxamide 1-?-d-ribofuranoside (AICAR), but not the AMPK inhibitor Compound C, significantly alleviated UA-induced reductions in NKA activity and NKA ?1 subunit expression on the cell membrane by reducing NKA degradation in lysosomes; sustained AICAR treatment also significantly alleviated activation of the NKA downstream molecules Src and interleukin-1? (IL-1?) in PTECs. AICAR further alleviated high UA-induced apoptosis, autophagy, and mitochondrial dysfunction. Although AMPK activation by metformin did not reduce serum UA levels in hyperuricemic rats, it significantly alleviated HUA-induced renal tubular injury and NKA signaling impairment in vivo with effects similar to those of febuxostat. Our study suggests that AMPK activation may temporarily compensate for HUA-induced renal injury. Sustained AMPK activation could reduce lysosomal NKA degradation and maintain NKA function, thus alleviating NKA downstream inflammation and protecting tubular cells from high UA-induced renal tubular injury.

SUBMITTER: Xiao J 

PROVIDER: S-EPMC6531502 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

AMPK alleviates high uric acid-induced Na<sup>+</sup>-K<sup>+</sup>-ATPase signaling impairment and cell injury in renal tubules.

Xiao Jing J   Zhu Sibo S   Guan Haochen H   Zheng Yuqi Y   Li Fengqin F   Zhang Xiaoli X   Guo Hui H   Wang Xiaojun X   Ye Zhibin Z  

Experimental & molecular medicine 20190522 5


One of the mechanisms in hyperuricemia (HUA)-induced renal tubular injury is the impairment of Na<sup>+</sup>-K<sup>+</sup>-ATPase (NKA) signaling, which further triggers inflammation, autophagy, and mitochondrial dysfunction and leads to cell injury. Here, we used RNA sequencing to screen the most likely regulators of NKA signaling and found that the liver kinase B1(LKB1)/adenosine monophosphate (AMP)-activated protein kinase (AMPK)/ mammalian target of rapamycin (mTOR) pathway was the most abu  ...[more]

Similar Datasets

| S-EPMC5898891 | biostudies-literature
| S-EPMC5533233 | biostudies-literature
| S-EPMC6117330 | biostudies-literature
| S-EPMC5550679 | biostudies-literature
| S-EPMC9483571 | biostudies-literature
| S-EPMC5626372 | biostudies-literature
| S-EPMC9485054 | biostudies-literature
| S-EPMC10587769 | biostudies-literature
| S-EPMC9055044 | biostudies-literature
| S-EPMC10576127 | biostudies-literature